Medication Safety Alert: Beware of obstacles that could lead to adverse drug events! Tep M. Kang, PharmD, BCPS Definition World Health Organization Any noxious and unintended reaction to a drug requiring positive action, and which occurs at doses normally used in humans for prophylaxis, diagnosis, or therapy. Importance of Adverse Drug Reactions Account for 5% of all hospital admissions Occur in 10-20% of hospital inpatients Cause deaths in 0.1% of medical inpatients Cause deaths in 0.01% of surgical inpatients Adversely affect patient’s quality of life Cause patient patients to lose confidence in their doctors Pirmohamed M et al. BMJ 1998;316:1295-8 Importance of Adverse Drug Reactions Increase costs of patient care Preclude use of drug in most patients, although they occur in only a few patients May mimic disease, resulting in unnecessary investigations and delay in treatment Pirmohamed M et al. BMJ 1998;316:1295-8 Information in the Literature 30% of hospitalized patients experienced an adverse drug event (Arch Int Med 1974; 134: 219-23) 0.7% of all hospitalized patients developed a serious, disabling, and clinically important adverse drug event during hospitalization (NEJM 1991; 324:377-84) 3-28% of hospital admissions were related to adverse drug events (NEJM 1974; 291:824-828) Information in the Literature In matched cases: ADE Mortality Rate (%) Length of Stay (Days) Mean Cost ($) No ADE 3.50 1.05 7.69 4.46 10,010 5,355 Significance p < 0.001 p < 0.001 p < 0.001 JAMA1997;277(4):301-6. Phases of Drug Development Potential Causes of ADEs Look-alike and sound-alike (LASA) Foreign drugs Dosage conversions Unacceptable abbreviations Illegible handwriting Magic words Over-the-counter products Natural medicine – herbal products The Look-Alikes… “A patient undergoing orthopedic surgery inadvertently received phenylephrine 10 mg/mL instead of metoclopramide 10 mg/mL. The event lead to pulmonary edema and cardiac arrest.” The Look-Alikes… The Look-Alikes… Midazolam or Furosemide? Which EDTA??? EDTA: ethylene diamine tetraacetic acid Edetate disodium: treat hypercalcemia Edetate calcium disodium: treat lead poisoning Both drugs are often referred to as EDTA Two reported deaths since 2005 due to mix-up Foreign Drugs with US Brand Names But With Different Active Ingredients IV-PO Conversions Oral Drug IV Dosage Adjustment Amiodarone 200 mg PO Levothyroxine 100 mcg PO Metoprolol 25 mg PO Morphine 30 mg PO Reduce PO dose by 50% Reduce PO dose by 50% Reduce PO dose 5-fold Reduce PO dose by 70% Unacceptable Abbreviations Unacceptable Acceptable U IU QD g CC QOD 1.0 .5 MS MSO4 MgSO4 TIW units international units daily microgram mL every other day 1 0.5 morphine sulfate morphine sulfate magnesium sulfate three times a week Illegible Handwriting Illegible Handwriting Illegible Handwriting Flexeril Tab 5 mg. #100, take 1 every 6 hours as needed for muscle spasms Neurontin 400 mg. #100, take 1 by mouth 3 times daily for pain. Promethazine with codeine. #120 mL, take 1 teaspoonful 4 times daily. Illegible Handwriting Illegible Handwriting Illegible Handwriting Methadone for pain was filled in place of Metadate for ADHD Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Illegible Handwriting Doctors and Illegible Handwriting Ambiguous Order Cerebyx vs. Dilantin Cerebyx 1.5 mg = Dilantin 1 mg Cerebyx 1 mg PE = Dilantin 1 mg Not your everyday prescription… Incorrect Dosage - Octreotide • Consultant recommended Octreotide 100 mcg SC Q8H • Order was written as Octreotide drip @ 100 mcg/hr Be Crystal Clear… “Magic Words” or “Red Flags” The patient is “on this medication at home.” “A specialist prescribed it.” The patient has been “titrated up to that dose.” This is a “special case.” The patient is “on a protocol.” “We always give it that way.” The Formulary, April 1999 “Patient told me that’s what he takes at home!” “Magic Words” or “Red Flags” The drug/dose was “recently published” or from a published study.” I got the order from the patient’s “prior medical records.” “Mom (or the patient) said they take it this way.” It was “on a list of medications that the patient gave me.” The Formulary, April 1999 FDA Investigating OTC Cough and Cold Products April 2007 Never proven to be safe in children < 6 years of age Why were these medications available in the market? FDA created this process to allow certain medications that were in use before 1972 to remain on the market without undergoing new clinical trials. Wellbutrin vs. Budeprion Budeprion dissolves faster, releasing 34% of the drug within the first two hours, compared with 8% for Wellbutrin. Michael Jackson & Propofol "There is no conceivable way this drug can be properly prescribed for home use." Contaminated Dietary Supplements Man lost his job over contaminated diet pill from Brazil According to the label, his diet pills, contained vitamin E, centella, senna, and cascara, among other “natural” ingredients. “amphetamine” N Engl J Med 361;16 October 15, 2009 An Old Drug with a New Warning Colchicine FDA Updates Prescribing Label Of Colchicine To Note Potential For Adverse Events. The drug "is now contraindicated in patients with renal or hepatic impairment and prescribed protease inhibitors." Warfarin – Drug Interactions Azathioprine: decrease INR by 3 fold Amiodarone: increase INR, decrease dose 30-50% Bactrim: increase INR Bosentin: increase dose 64% Carbamazepine: dec INR, bump dose 2-3 fold Azithromycin – QTc Prolongation For every 21,000 outpatient prescriptions written for azithromycin, one cardiovascular death occurred in excess of those observed with the same number of amoxicillin prescriptions NEJM 368;18: May 2, 2013 Drugs withdrawn from the market… Jun 1992 Omniflox (temafloxacin, Abbott Lab) Hypoglycemia and hemolytic anemia Sep 1997 Redux (dexfenfluramine, Wyeth Ayerst) Cardiac valvular dysfunction Dec 1997 LMW heparin (enoxaparin, RPR) Spinal hemorrhage or hematoma Feb 1998 Seldane (terfenadine, Hoechst Marion Roussel) Cardiovascular event Jun 1998 Posicor (mibefradil, Hoffman La Roche) Drug-drug interactions Jun 1999 Trovan (trovafloxacin, Pfizer) Liver failure Jul 1999 Abbokinase (urokinase, Abbott Lab) Manufacturing deficiencies - human kidney cells Oct 1999 Raxar (grepafloxacin, Glaxo Wellcome) QTc prolongation, arrhythmia, sudden death Mar 2000 Propulsid (cisapride, Janssen) Cardiovascular events Mar 2000 Rezulin (troglitazone, Parke-Davis) Liver failure Aug 2001 Baycol (cerivastatin, Bayer) Fatal rhabdomyolysis May 2004 Serzone (nefazodone, BMS) Liver failure Sep 2004 Vioxx (rofecoxib, Merck) Adenomatous Polyp Prevention Trial (18 months) Increase risk of thromboembolic event (3.5% vs. 1.9%) Feb 2005 Tysabri (natalizumab, Biogen/Idec) Indicated for multiple sclerosis Progressive Multifocal Leukoencephalopathy 3 case reports Mar 2007 Tegaserod (Zelnorm, Novartis) Indication: irritable bowel syndrome/chronic constipation Increased risk of cardiovascular (ischemic) event Mar 2007 Pergolide (Permax, Valeant Pharma) An ergot derivative dopamine receptor agonist Treat Parkinson’s disease Increased risk of serious heart-valve damage March 2008 Heparin (Baxter) Raw heparin is derived from pig intestines Caused by oversulfated chondroitin sulfate - made from animal cartilage, has been reported to cause side effects from nausea and vomiting to shortness of breath and substantial drops in blood pressure Resulted in 81 deaths Preventability Assessment Was the drug appropriate in the patient’s clinical condition? Was the dose, route, or frequency appropriate for the patient’s age, weight, &/or disease state? Were required drug monitoring tests not performed? Was there a history of allergy or previous reaction? Was poor compliance involved? Was a toxic serum drug concentration determined? Was a drug interaction involved The End